Magnetic resonance imaging in breast cancer screening and diagnosis

REVIEW
Batil Alonazi

 
International Journal of Biomedicine. 2022;12(1):89-94.
DOI: 10.21103/Article12(1)_RA4
Originally published March 10, 2022

Abstract: 

The purpose of this article was to evaluate the diagnostic and screening effectiveness of breast MRI (BMRI) protocols for detecting breast cancer. The current review was based on prior research published in English databases such as PubMed and ScienceDirect in scientific articles published between 2010 and 2020 with the keywords "breast cancer MRI," "diagnostic," "dense breast," "risk factors," and "imaging." BMRI is the most sensitive imaging modality for detecting breast cancer. Annual BMRI is recommended for screening women who are at high risk for breast cancer in addition to mammography. Abbreviated MRI, with shorter image acquisition and interpretation times, increases the availability of breast MRI and reduces the costs. Unenhanced MRI parameters such as DWI are under investigation to be added to abbreviated MRI protocols. It seems feasible to offer a cost‐effective screening breast DCE‐MRI to a broader population.

Keywords: 
breast cancer • MRI • imaging protocol
References: 
  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. 
  2. Tamam N, Al-Mugren KS, Alrebdi HI, Sulieman A, Abdelbasset WK. Evaluating the Quality of Life and Sleep Quality in Saudi Women with Breast Cancer-Related Lymphedema: A Cross-Sectional Correlational Study. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211046192. doi: 10.1177/15347354211046192. 
  3. Tamam N, Salah H, Rabbaa M, Abuljoud M, Sulieman A, Alkhorayef M, Bradley D.Evaluation of patients radiation dose during mammography imaging procedure. Radiation Physics and Chemistry.2021;188,1-7.
  4. Sulieman A, Serhan O, Al-Mohammed HI, Mahmoud MZ, Alkhorayef M, Alonazi B, Manssor E, Yousef A. Estimation of cancer risks during mammography procedure in Saudi Arabia. Saudi J Biol Sci. 2019 Sep;26(6):1107-1111. doi: 10.1016/j.sjbs.2018.10.005.
  5. Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac J Cancer Prev. 2016;17(S3):43-6. doi: 10.7314/apjcp.2016.17.s3.43. 
  6. Apostolou P, Fostira F. Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int. 2013;2013:747318. doi: 10.1155/2013/747318. 
  7. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66-71. doi: 10.1126/science.7545954.
  8. Gorodetska I, Kozeretska I, Dubrovska A. BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance. J Cancer. 2019 May 14;10(9):2109-2127. doi: 10.7150/jca.30410. 
  9. Godet I, Gilkes DM. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. 2017 Feb;4(1):10.15761/ICST.1000228. doi: 10.15761/ICST.1000228. 
  10. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003 May;72(5):1117-30. doi: 10.1086/375033. 
  11. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007 Apr 10;25(11):1329-33. doi: 10.1200/JCO.2006.09.1066. 
  12. Fahad Ullah M. Breast Cancer: Current Perspectives on the Disease Status. Adv Exp Med Biol. 2019;1152:51-64. doi: 10.1007/978-3-030-20301-6_4. 
  13. Henson LA, Maddocks M, Evans C, Davidson M, Hicks S, Higginson IJ. Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue. J Clin Oncol. 2020 Mar 20;38(9):905-914. doi: 10.1200/JCO.19.00470. 
  14. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020. Available from:  https://gco.iarc.fr/today
  15. Lynge E, Vejborg I, Andersen Z, von Euler-Chelpin M, Napolitano G. Mammographic Density and Screening Sensitivity, Breast Cancer Incidence and Associated Risk Factors in Danish Breast Cancer Screening. J Clin Med. 2019 Nov 19;8(11):2021. doi: 10.3390/jcm8112021.
  16. Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017 Apr;283(1):49-58. doi: 10.1148/radiol.2016161174. 
  17. Sree SV, Ng EY, Acharya RU, Faust O. Breast imaging: A survey. World J Clin Oncol. 2011 Apr 10;2(4):171-8. doi: 10.5306/wjco.v2.i4.171.
  18. Abulkhair OA, Al Tahan FM, Young SE, Musaad SM, Jazieh AR. The first national public breast cancer screening program in Saudi Arabia. Ann Saudi Med. 2010 Sep-Oct;30(5):350-7. doi: 10.4103/0256-4947.67078. 
  19. Coop P, Clawson C. Tomosynthesis as a screening tool for breast cancer: A systematic review. Radiography. 2016, e190-e195.
  20. Drukteinis JS, Mooney BP, Flowers CI, Gatenby RA. Beyond mammography: new frontiers in breast cancer screening. Am J Med. 2013 Jun;126(6):472-9. doi: 10.1016/j.amjmed.2012.11.025.
  21. Anstey EH, Shoemaker ML, Barrera CM, O'Neil ME, Verma AB, Holman DM. Breastfeeding and Breast Cancer Risk Reduction: Implications for Black Mothers. Am J Prev Med. 2017 Sep;53(3S1):S40-S46. doi: 10.1016/j.amepre.2017.04.024. 
  22. Oldrini G, Fedida B, Poujol J, Felblinger J, Trop I, Henrot P, Darai E, Thomassin-Naggara I. Abbreviated breast magnetic resonance protocol: Value of high-resolution temporal dynamic sequence to improve lesion characterization. Eur J Radiol. 2017 Oct;95:177-185. doi: 10.1016/j.ejrad.2017.07.025. 
  23. Ahmed A, Baldo A, Sulieman A, Mirghani H, Abolaban FA, Suliman II, Salih I. Optimisation of T2 and T2* sequences in MRI for better quantification of iron on transfused dependent sickle cell patients. Sci Rep. 2021 Apr 19;11(1):8513. doi: 10.1038/s41598-021-88116-8. 
  24. Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert FJ, Helbich T, Heywang-Köbrunner SH, Kaiser WA, Kerin MJ, Mansel RE, Marotti L, Martincich L, Mauriac L, Meijers-Heijboer H, Orecchia R, Panizza P, Ponti A, Purushotham AD, Regitnig P, Del Turco MR, Thibault F, Wilson R. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010 May;46(8):1296-316. doi: 10.1016/j.ejca.2010.02.015. 
  25. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG; Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004 Jul 29;351(5):427-37. doi: 10.1056/NEJMoa031759. 
  26. Hollingsworth AB. Redefining the sensitivity of screening mammography: A review. Am J Surg. 2019 Aug;218(2):411-418. doi: 10.1016/j.amjsurg.2019.01.039.
  27. Salem DS, Kamal RM, Mansour SM, Salah LA, Wessam R. Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up. J Thorac Dis. 2013 Jun;5 Suppl 1(Suppl 1):S9-S18. doi: 10.3978/j.issn.2072-1439.2013.05.02. 
  28. ACR Ppractice parameter for the performance of contrast enhanced magnetic resonance imaging (MRI) of the breast (2018). Available from: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/mr-contrast-br....
  29. Alcantara D, Leal MP, García-Bocanegra I, García-Martín ML. Molecular imaging of breast cancer: present and future directions. Front Chem. 2014 Dec 18;2:112. doi: 10.3389/fchem.2014.00112.
  30. Ibrahim MA, Hazhirkarzar B, Dublin AB. Gadolinium Magnetic Resonance Imaging. 2021 Jul 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 29494094.
  31. Kjaer A. Molecular imaging of cancer using PET and SPECT. Adv Exp Med Biol. 2006;587:277-84. PMID: 17163171.
  32. Rosenkrantz AB, Friedman K, Chandarana H, Melsaether A, Moy L, Ding YS, Jhaveri K, Beltran L, Jain R. Current Status of Hybrid PET/MRI in Oncologic Imaging. AJR Am J Roentgenol. 2016 Jan;206(1):162-72. doi: 10.2214/AJR.15.14968. 
  33. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS, Russell CA; American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89. doi: 10.3322/canjclin.57.2.75.
  34. Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. J Am Coll Radiol. 2018 Mar;15(3 Pt A):408-414. doi: 10.1016/j.jacr.2017.11.034. 
  35. Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2016 Feb 16;164(4):268-78. doi: 10.7326/M15-1789. Epub 2016 Jan 12. 
  36. Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB, DePeri ER, Bluemke DA, Schnall MD; ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007 Mar 29;356(13):1295-303. doi: 10.1056/NEJMoa065447.
  37. Lehman CD, Blume JD, Thickman D, Bluemke DA, Pisano E, Kuhl C, Julian TB, Hylton N, Weatherall P, O'loughlin M, Schnitt SJ, Gatsonis C, Schnall MD. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005 Oct 1;92(1):9-15; discussion 15-6. doi: 10.1002/jso.20350. 
  38. Kim JY, Cho N, Koo HR, Yi A, Kim WH, Lee SH, Chang JM, Han W, Moon HG, Im SA, Noh DY, Moon WK. Unilateral breast cancer: screening of contralateral breast by using preoperative MR imaging reduces incidence of metachronous cancer. Radiology. 2013 Apr;267(1):57-66. doi: 10.1148/radiol.12120629.
  39. Flanagan FL, Murray JG, Gilligan P, Stack JP, Ennis JT. Digital subtraction in Gd-DTPA enhanced imaging of the breast. Clin Radiol. 1995 Dec;50(12):848-54. doi: 10.1016/s0009-9260(05)83106-x. 
  40. Mountford CE, Stanwell P, Ramadan S. Breast MR imaging at 3.0 T. Radiology. 2008 Jul;248(1):319-20; author reply 320. doi: 10.1148/radiol.2481072049. P
  41. Mann RM, Cho N, Moy L. Breast MRI: State of the Art. Radiology. 2019 Sep;292(3):520-536. doi: 10.1148/radiol.2019182947.
  42. Hendrick RE. High-quality breast MRI. Radiol Clin North Am. 2014 May;52(3):547-62. doi: 10.1016/j.rcl.2013.12.002.
  43. Kuhl C. The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007 Aug;244(2):356-78. doi: 10.1148/radiol.2442051620.
  44. Cheung HS, Tse GM, Lai SY, Yeung DK. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast. Magn Reson Imaging. 2004 Nov;22(9):1259-64. doi: 10.1016/j.mri.2004.09.001. 
  45. Mango VL, Morris EA, David Dershaw D, Abramson A, Fry C, Moskowitz CS, Hughes M, Kaplan J, Jochelson MS. Abbreviated protocol for breast MRI: are multiple sequences needed for cancer detection? Eur J Radiol. 2015 Jan;84(1):65-70. doi: 10.1016/j.ejrad.2014.10.004.
  46. Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB. Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol. 2014 Aug 1;32(22):2304-10. doi: 10.1200/JCO.2013.52.5386. 
  47. Leithner D, Moy L, Morris EA, Marino MA, Helbich TH, Pinker K. Abbreviated MRI of the Breast: Does It Provide Value? J Magn Reson Imaging. 2019 Jun;49(7):e85-e100. doi: 10.1002/jmri.26291. 
  48. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology. 1989 Mar;170(3 Pt 1):681-6. doi: 10.1148/radiology.170.3.2916021. 
  49. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology. 1999 Apr;211(1):101-10. doi: 10.1148/radiology.211.1.r99ap38101. 
  50. Daniel BL, Yen YF, Glover GH, Ikeda DM, Birdwell RL, Sawyer-Glover AM, Black JW, Plevritis SK, Jeffrey SS, Herfkens RJ. Breast disease: dynamic spiral MR imaging. Radiology. 1998 Nov;209(2):499-509. doi: 10.1148/radiology.209.2.9807580. 
  51. Partridge SC, Stone KM, Strigel RM, DeMartini WB, Peacock S, Lehman CD. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions. Acad Radiol. 2014 Sep;21(9):1195-203. doi: 10.1016/j.acra.2014.04.013. 
  52. Sheth D, Abe H. Abbreviated MRI and Accelerated MRI for Screening and Diagnosis of Breast Cancer. Top Magn Reson Imaging. 2017 Oct;26(5):183-189. doi: 10.1097/RMR.0000000000000140.
  53. Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS. Abbreviated screening protocol for breast MRI: a feasibility study. Acad Radiol. 2015 Sep;22(9):1157-62. doi: 10.1016/j.acra.2015.06.004. 
  54. Moschetta M, Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G. Abbreviated Combined MR Protocol: A New Faster Strategy for Characterizing Breast Lesions. Clin Breast Cancer. 2016 Jun;16(3):207-11. doi: 10.1016/j.clbc.2016.02.008.
  55. Harvey SC, Di Carlo PA, Lee B, Obadina E, Sippo D, Mullen L. An Abbreviated Protocol for High-Risk Screening Breast MRI Saves Time and Resources. J Am Coll Radiol. 2016 Apr;13(4):374-80. doi: 10.1016/j.jacr.2015.08.015. 
  56. Mann RM, Mus RD, van Zelst J, Geppert C, Karssemeijer N, Platel B. A novel approach to contrast-enhanced breast magnetic resonance imaging for screening: high-resolution ultrafast dynamic imaging. Invest Radiol. 2014 Sep;49(9):579-85. doi: 10.1097/RLI.0000000000000057. 
  57. Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, et al. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening. JAMA. 2020 Feb 25;323(8):746-756. doi: 10.1001/jama.2020.0572. Erratum in: JAMA. 2020 Mar 24;323(12):1194.
  58. Leithner D, Wengert GJ, Helbich TH, Thakur S, Ochoa-Albiztegui RE, Morris EA, Pinker K. Clinical role of breast MRI now and going forward. Clin Radiol. 2018 Aug;73(8):700-714. doi: 10.1016/j.crad.2017.10.021. 
  59. Evans DG, Maxwell AJ. MRI Screening in Women With a Personal History of Breast cancer. J Natl Cancer Inst. 2015 Nov 30;108(3):djv373. doi: 10.1093/jnci/djv373. 
  60. Xing D, Lv Y, Sun B, Xie H, Dong J, Hao C, Chen Q, Chi X. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions. J Comput Assist Tomogr. 2019 Mar/Apr;43(2):245-251. doi: 10.1097/RCT.0000000000000832. 
  61. Coolen BF, Calcagno C, van Ooij P, Fayad ZA, Strijkers GJ, Nederveen AJ. Vessel wall characterization using quantitative MRI: what's in a number? MAGMA. 2018 Feb;31(1):201-222. doi: 10.1007/s10334-017-0644-x.
  62. Xiao YD, Paudel R, Liu J, Ma C, Zhang ZS, Zhou SK. MRI contrast agents: Classification and application (Review). Int J Mol Med. 2016 Nov;38(5):1319-1326. doi: 10.3892/ijmm.2016.2744. 
  63. Marino MA, Helbich T, Baltzer P, Pinker-Domenig K. Multiparametric MRI of the breast: A review. J Magn Reson Imaging. 2018 Feb;47(2):301-315. doi: 10.1002/jmri.25790. 
  64. Xiang W, Rao H, Zhou L. A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer. Thorac Cancer. 2020 Jun;11(6):1423-1432. doi: 10.1111/1759-7714.13400.
  65. Łuczyńska E, Heinze-Paluchowska S, Hendrick E, Dyczek S, Ryś J, Herman K, Blecharz P, Jakubowicz J. Comparison between breast MRI and contrast-enhanced spectral mammography. Med Sci Monit. 2015 May 12;21:1358-67. doi: 10.12659/MSM.893018.

Download Article
Received December 19, 2021.
Accepted January 13, 2022.
©2022 International Medical Research and Development Corporation.